20472EGP
- Active ingredient
- blood-coagulation factor vii
- Strength
- 1 mg
- Form
- vial
- Manufacturer
- novo nordisk
- Route
- injection
Uses
Used to control and prevent bleeding episodes in patients with specific coagulation disorders including hemophilia with inhibitors.
Do not use if
Hypersensitivity to factor VII preparations or product components.
Side effects
Headache, fever, injection-site reactions, and thromboembolic events may occur.
Warnings
Use cautiously in patients at risk of thrombosis. Clinical monitoring is required.
How it works
Recombinant factor VII promotes coagulation by activating the clotting cascade and enhancing thrombin generation.
Storage
Store according to manufacturer instructions, usually refrigerated.